ZP1846 Publications
  • 2010

    8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

    Read More >

  • Meet us

    The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

    Read More >

ZP1846 Publications

Petersen, Y.M., Björkenberg, B., Derikx, J.P.M.  and Buurman, W.A.:
Plasma citrulline is a reliable marker of chemotherapy-induced small intestinal atrophy in rats administered single or multiple cycles of chemotherapy.
Abstract for poster at the 2008 International Symposium on Supportive Care in Cancer (MASCC), Houston, Texas, June 26-28, 2008.
Poster
Support. Care Cancer, 2008, 16, 676-677

Petersen, Y.M., Björkenberg, B., Derikx, J.P.M. and Buurman, W.A.:
Plasma citrulline is a reliable marker of chemotherapy-induced small intestinal atrophy in Sprague-Dawley rats administered single or multiple cycles of chemotherapy.
Abstract for presentation at “The Mucositis Research Workshop”, at the 2008 International Symposium on Supportive Care in Cancer (MASCC), Houston, Texas, June 26-28, 2008.
Presentation 

Petersen, Y.M., Thorkildsen, C., Petersen, J.S. and Kjølbye, A.L:
ZP 1846, a Novel Potential Candidate for the Treatment of Chemotherapy-Induced Diarrhea
Abstract for Course: Gastrointestinal Response to Injury - Canada 2007.
3rd October – 6th October 2007, Montebello, Quebec, Canada

Petersen, Y.M., Thorkildsen, C., Petersen, J.S. and Kjølbye, A.L:
ZP 1846, a Novel Potential Candidate for the Treatment of Chemotherapy-Induced Diarrhea.
Poster: Multinational Association of Supportive Care in Cancer (MASCC) - 20th International Symposium «Supportive Care in Cancer». St.Gallen, Switzerland. 28th - 30th June 2007.
Support Care Cancer, 2007, 15, 772-773

Petersen, Y.M., Jepsen, T., Thorkildsen, C., Larsen, B.D., Petersen, J.S. and Kjølbye, A.:
ZP 1846, a novel stable, high efficacy glucagon-like peptide 2 mimetic, stimulates small intestinal growth and prevents 5-fluorouracil-induced small intestinal injury in c57bl mice.
Annual meeting - Pharmacology of Membrane Proteins: from molecule to clinic. Joint meeting between The German Pharmacological Society and The Danish Society of Pharmacology and Toxicology, 21-22 June 2007, Copenhagen, Denmark
Poster Abstract No. 19, Meeting Programme p 40
Poster

Petersen, Y. M., Jepsen, T., Thorkildsen, C., Larsen, B.D., Petersen, J.S. and Kjølbye, A.:
ZP 1846, a novel stable, high efficacy glucagon-like peptide 2 mimetic, stimulates small intestinal growth and prevents 5-fluorouracil-induced small intestinal injury in C57BL mice.
Abstract for 14th United European Gastroenterology Week (UEGW 2006), 21-25 October 2006, Berlin, Germany. Presentation OP-G-213
Gut, 2006, 55, Supplement No. V, A48

Petersen, Y.M., Larsen, B.D., and Petersen, J.S.:
[Gly2]GLP-2 Administration Both Prior To And Concurrently With Chemotherapy Inhibits Small Intestinal Atrophy And Attenuates Body Weight Loss in Mice.
Poster at American Gastroenterological Association - Digestive Diseases Week. Chicago, Illinois, USA, May 12th-19th 2005.
Poster presentation

Petersen, Y.M., Larsen, B.D. and Petersen, J.S.:
[Gly2]GLP-2 inhibits chemotherapy-induced small intestinal atrophy and body weight loss in mice.
Poster B6 for Dansk Farmakologi 2005, 19 Januar, 2005, SDU, Odense, Denmark, Abstract
Poster presentation 

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.



Related links